Pharmacovigilance and radiologists: How well do they get along?
- PMID: 32903029
- PMCID: PMC8519654
- DOI: 10.1259/bjr.20200596
Pharmacovigilance and radiologists: How well do they get along?
Abstract
Objectives: Considering the growing use of imaging modalities and contrast agents, radiologists are prone to encounter adverse drug reactions (ADR). In the current study, we mainly aim to evaluate the knowledge of radiologists regarding pharmacovigilance (PV). Also, we intend to gather information about their previous ADR experiences. Secondarily, we hope to increase the awareness about contrast-medium-related ADRs and attract attention to the importance of properly reporting these ADRs.
Methods: A survey was generated by using an online survey webpage, and the relevant link was e-mailed to radiologists and radiology residents. The survey begins with a short explanation about the study. The second section contains questions about PV knowledge level, and the final section aims to gather information about the experienced ADRs.
Results: The survey was completed by 202 participants. 65.3% stated that they were aware of PV. 24.8% of the participants said that they know the national PV program. 97% told that they knew the term ADR. 66.3% of the participants encountered an ADR. 53.7% of them reported these ADRs. 70.8% of them reported these ADRs to a clinician.
Conclusions: Radiologists encounter ADRs almost as frequently as the other doctors. Their awareness about PV is similar with other healthcare professionals. They have fewer information about TUFAM and PvCPs. Radiologists generally prefer to communicate with a clinician about an ADR. Overall condition of radiologists about PV is quite similar with other healthcare professionals and education can improve it, as for the others.
Advances in knowledge: Radiologists encounters ADRs almost as frequently as the other doctors. Overall condition of radiologists about PV is quite similar with other healthcare professionals and education can improve it, as for the others.
Conflict of interest statement
Figures
Similar articles
-
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.Per Med. 2022 Nov;19(6):495-507. doi: 10.2217/pme-2022-0030. Epub 2022 Oct 14. Per Med. 2022. PMID: 36239598
-
Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.BMC Health Serv Res. 2019 Dec 3;19(1):926. doi: 10.1186/s12913-019-4775-9. BMC Health Serv Res. 2019. PMID: 31796034 Free PMC article.
-
Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor-Leste: A Cross-Sectional Survey.Clin Transl Sci. 2025 Jan;18(1):e70134. doi: 10.1111/cts.70134. Clin Transl Sci. 2025. PMID: 39844473 Free PMC article.
-
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.Curr Med Res Opin. 2022 Jan;38(1):145-154. doi: 10.1080/03007995.2021.1997287. Epub 2021 Nov 3. Curr Med Res Opin. 2022. PMID: 34694167
-
Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.Curr Drug Saf. 2024;19(2):172-190. doi: 10.2174/1574886318666230428144120. Curr Drug Saf. 2024. PMID: 37132145 Review.
Cited by
-
Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey.World J Clin Cases. 2023 Jul 16;11(20):4865-4873. doi: 10.12998/wjcc.v11.i20.4865. World J Clin Cases. 2023. PMID: 37583988 Free PMC article.
-
Pharmacy practice and policy research in Türkiye: a systematic review of literature.J Pharm Policy Pract. 2024 Aug 12;17(1):2385939. doi: 10.1080/20523211.2024.2385939. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39139388 Free PMC article. Review.
References
-
- WHO. Essential medicines and health products. 2020. Available from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharm....
-
- Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse drug reaction reporting pattern in turkey: analysis of the National database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes 2016; 3: 33–43. doi: 10.1007/s40801-015-0054-1 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials